Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial

Host: Pavani Chalasani, MD, MPH Guest: Hope S. Rugo, MD, FASCO Results from the TROPiCS-02 trial may impact survival for patients with receptor–positive/HER2-negative breast cancer. To find out why, Dr. Hope Rugo from the University of California San Francisco Comprehensive Cancer Center joins Dr. Pavani Chalasani to talk about the study and how it might impact the future of breast cancer treatment.